CINA-ICH

Avicenna.AI

The CINA-ICH solution provides automated detection and prioritization of acute intracerebral hemorrhage on non-contrast CT (NCCT).

Product specifications

Information source: Vendor
Last updated: Nov. 21, 2022

General
Product name	CINA-ICH
Company	Avicenna.AI
Subspeciality	Neuro
Modality	CT
Disease targeted	Intracranial Hemorrhage, Stroke, Trauma
Key-features	Intracranial Hemorrhage detection, notification
Suggested use	Before: adapting worklist order, flagging acute findings
Data characteristics
Population	Suspicion of stroke, Suspicion of head trauma
Input	Non contrast CT
Input format	DICOM
Output	segmentation contour, worklist order, notification
Output format	DICOM SC, GSPS
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis	Automatically, right after the image acquisition
Processing time	10 - 60 seconds
Certification
CE	Certified, Class I , MDD
FDA	510(k) cleared, Class II
Market presence
On market since	02-2020
Distribution channels	Eureka Clinical AI, Canon Automation Platform, Blackford, Arterys, Nuance AI Marketplace, Sectra Amplifier Store, deepcOS, Incepto, CARPL.ai, Calantic
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Pay-per-use, Subscription
Based on	Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance	Assessment of an Artificial Intelligence Algorithm for Detection of Intracranial Hemorrhage (read) Validation of a Deep Learning Tool in the Detection of Intracranial Hemorrhage and Large Vessel Occlusion (read)
Non-peer reviewed papers on performance
Other relevant papers